Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionStratos Wealth Partners, LTD.
Latest Disclosed Ownership33,919 shares
Latest Disclosed Value $ 11,934,481
Stratos Wealth Partners, LTD. reports 7.90% increase in ownership of AMGN / Amgen Inc.

On April 28, 2026 - Stratos Wealth Partners, LTD. filed a 13F-HR form disclosing ownership of 33,919 shares of Amgen Inc. (CH:AMGN) valued at $11,934,481 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 31,437 shares of Amgen Inc.. This represents a change in shares of 7.90% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F AMGEN COM 031162100 33,919 2,482 7.90 11,934 15.99 0.1357
2026-01-20 2025-12-31 13F AMGEN COM 031162100 31,437 147 0.47 10,290 16.52 0.1163
2025-11-06 2025-09-30 13F AMGEN COM 031162100 31,290 3,045 10.78 8,830 11.97 0.1041
2025-07-29 2025-06-30 13F AMGEN COM 031162100 28,245 2,899 11.44 7,886 -0.13 0.1066
2025-04-30 2025-03-31 13F AMGEN COM 031162100 25,346 -1,788 -6.59 7,897 11.65 0.1202
2025-01-27 2024-12-31 13F AMGEN COM 031162100 27,134 -1,895 -6.53 7,072 -24.39 0.0998
2024-10-17 2024-09-30 13F AMGEN COM 031162100 29,029 3,658 14.42 9,354 17.99 0.1350
2024-07-24 2024-06-30 13F AMGEN COM 031162100 25,371 133 0.53 7,927 10.48 0.1269
2024-04-16 2024-03-31 13F AMGEN COM 031162100 25,238 326 1.31 7,176 0.00 0.1189
2024-01-24 2023-12-31 13F AMGEN COM 031162100 24,912 946 3.95 7,175 11.40 0.1338
2023-10-24 2023-09-30 13F AMGEN COM 031162100 23,966 4,050 20.34 6,441 45.69 0.1387
2023-07-18 2023-06-30 13F AMGEN COM 031162100 19,916 1,864 10.33 4,422 1.31 0.1002
2023-04-27 2023-03-31 13F AMGEN COM 031162100 18,052 -1,772 -8.94 4,364 -16.17 0.1163
2023-01-19 2022-12-31 13F AMGEN COM 031162100 19,824 919 4.86 5,207 22.18 0.1317
2022-10-24 2022-09-30 13F AMGEN COM 031162100 18,905 -596 -3.06 4,261 -10.20 0.1190
2022-07-22 2022-06-30 13F AMGEN COM 031162100 19,501 -438 -2.20 4,745 -1.60 0.1196
2022-04-26 2022-03-31 13F AMGEN COM 031162100 19,939 -11,689 -36.96 4,822 -32.23 0.1077
2022-01-14 2021-12-31 13F AMGEN COM 031162100 31,628 -256 -0.80 7,115 4.94 0.1575
2021-10-19 2021-09-30 13F AMGEN COM 031162100 31,884 -762 -2.33 6,780 -14.80 0.1726
2021-07-19 2021-06-30 13F AMGEN COM 031162100 32,646 556 1.73 7,958 -0.33 0.1981
2021-04-27 2021-03-31 13F AMGEN COM 031162100 32,090 78 0.24 7,984 8.48 0.2210
2021-01-29 2020-12-31 13F AMGEN COM 031162100 32,012 -626 -1.92 7,360 -11.27 0.2185
2020-10-29 2020-09-30 13F AMGEN COM 031162100 32,638 -113 -0.35 8,295 7.38 0.2723
2020-07-28 2020-06-30 13F AMGEN COM 031162100 32,751 1,557 4.99 7,725 22.15 0.2752
2020-05-04 2020-03-31 13F AMGEN COM 031162100 31,194 5,147 19.76 6,324 0.72 0.2899
2020-01-29 2019-12-31 13F AMGEN COM 031162100 26,047 274 1.06 6,279 25.91 0.2466
2019-11-12 2019-09-30 13F/A-1 AMGEN COM 031162100 25,773 16 0.06 4,987 5.08 0.2156
2019-11-12 2019-09-30 13F AMGEN COM 031162100 290 -25,467 5 190.8251
2019-08-06 2019-06-30 13F AMGEN COM 031162100 25,757 522 2.07 4,746 -1.00 0.2055
2019-05-07 2019-03-31 13F AMGEN COM 031162100 25,235 61 0.24 4,794 -2.18 0.2156
2019-02-08 2018-12-31 13F AMGEN COM 031162100 25,174 25,174 4,901 0.2527
2018-11-02 2018-09-30 13F AMGEN COM 031162100 0 -25,746 -100.00 0 -100.00
2018-08-13 2018-06-30 13F AMGEN COM 031162100 25,746 -1,929 -6.97 4,752 0.70 0.2120
2018-05-10 2018-03-31 13F AMGEN COM 031162100 27,675 -23,049 -45.44 4,719 -46.50 0.1987
2018-02-09 2017-12-31 13F AMGEN COM 031162100 50,724 -3,639 -6.69 8,821 -12.97 0.3958
2017-11-07 2017-09-30 13F AMGEN COM 031162100 54,363 54,363 10,136 0.4785
2017-05-11 2017-03-31 13F AMGEN COM 031162100 0 -43,669 -100.00 0 -100.00
2017-02-02 2016-12-31 13F AMGEN COM 031162100 43,669 4,412 11.24 6,385 -2.49 0.3970
2016-11-01 2016-09-30 13F AMGEN COM 031162100 39,257 3,776 10.64 6,548 21.30 0.4417
2016-08-12 2016-06-30 13F AMGEN COM 031162100 35,481 35,481 0.00 5,398 0.4003
2016-05-09 2016-03-31 13F AMGEN COM 031162100 0 -25,828 -100.00 0 -100.00
2016-02-16 2015-12-31 13F AMGEN COM 031162100 25,828 25,828 0.00 4,193 0.3496
2014-11-06 2014-09-30 13F AMGEN COM 031162100 0 -13,613 -100.00 0 -100.00
2014-07-17 2014-06-30 13F/A-1 AMGEN COM 031162100 13,613 13,613 1,615 0.5386
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.